-
Signature
-
/s/ George A. Eldridge, Attorney-in-Fact
-
Issuer symbol
-
JBIO
-
Transactions as of
-
28 Mar 2024
-
Net transactions value
-
-$246,240
-
Form type
-
4
-
Filing time
-
01 Apr 2024, 18:00:19 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
AVTE |
Common Stock |
Options Exercise |
$19,260 |
+9,000 |
+277% |
$2.14* |
12,251 |
28 Mar 2024 |
Direct |
F1 |
| transaction |
AVTE |
Common Stock |
Sale |
$265,500 |
-9,000 |
-73% |
$29.50 |
3,251 |
28 Mar 2024 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
AVTE |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-9,000 |
-9.1% |
$0.000000 |
89,510 |
28 Mar 2024 |
Common Stock |
9,000 |
$2.14 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: